retatrutide eli lilly Prepares for FDA Filing Following Additional Phase 3 Data in Diabetes, CVD Lilly announces more next-gen obesity

Department of Health and Human Services issued a report warning that dozens of weight loss and immune system supplements have illegal claims of curing or treating disease on their labels and/or lack the scientific evidence to support such label claims

This hormone provides the anabolic foundation that makes building muscle during caloric deficit possible

PT-141(bremelanotide) binds to melanocortin receptors in the brain to increase arousal and desire

As more data becomes available, Retatrutide may play a significant role in helping individuals with obesity, insulin resistance, PCOS, and metabolic health challenges achieve sustainable weight loss outcomes.